Sinopharm Weiqida Pharmaceutical Ltd is a private limited company that can be found at 225 City Rd, London EC1V 1JT. This 5 months-old company, incorporated on 2023-12-05 is run by 1 director.
Director Weijun C., appointed on 05 December 2023.
The company is categorised as "manufacture of pharmaceutical preparations" (Standard Industrial Classification code: 21200), "manufacture of basic pharmaceutical products" (Standard Industrial Classification: 21100), "regulation of health care, education, cultural and other social services, not incl. social security" (Standard Industrial Classification: 84120). According to official records there was a name change on 2023-12-08 and their previous name was Sinopharm Weiqida Pharmaceutical Co., Limited.
| Office Address | 225 City Rd |
| Town | London |
| Post code | EC1V 1JT |
| Country of origin | United Kingdom |
| Registration Number | 15329874 |
| Date of Incorporation | Tue, 5th Dec 2023 |
| Industry | Manufacture of pharmaceutical preparations |
| Industry | Manufacture of basic pharmaceutical products |
| End of financial Year | 31st December |
| Company age | 5 months |
| Account next due date | Fri, 5th Sep 2025 (483 days left) |
| Return next due date | Wed, 18th Dec 2024 (222 days left) |
Position: Director
Appointed: 05 December 2023
The register of persons with significant control that own or control the company is made up of 1 name. As BizStats established, there is Weijun C. The abovementioned PSC has 75,01-100% voting rights and has 75,01-100% shares.
Weijun C.
| Notified on | 5 December 2023 |
| Nature of control: |
75,01-100% shares 75,01-100% voting rights right to appoint and remove directors |
| Sinopharm Weiqida Pharmaceutical | December 8, 2023 |
| Type | Category | Free download | |
|---|---|---|---|
| CERTNM |
Company name changed sinopharm weiqida pharmaceutical co., LIMITEDcertificate issued on 08/12/23 filed on: 8th, December 2023 |
change of name | Free Download (3 pages) |
| NM01 |
Resolution of change of name |
change of name |
© bizstats.co.uk 2024.
Terms of Use and Privacy Policy